Alpha Casts - AI Market Intelligence
A late-stage AstraZeneca trial miss and Apollo’s caution about a slower AI payoff punctuate a day of mixed corporate beats and governance moves. Investors are parsing strong consumer prints in apparel and petrol windfalls against legal and pipeline risks, while debates intensify over whether to lean risk‑on in growth allocations.
400 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity Alpha Casts - AI Market Intelligence-yhteisöön!